Status:
SUSPENDED
Utility Of Citogenex Administration In Patients With Colon-Rectal Cancer
Lead Sponsor:
University of Palermo
Conditions:
Colonic Neoplasms
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
The main aim of the present study is to test the efficacy and safety of CITOGENEX administration in patients with colon-rectal cancer.
Detailed Description
CITOGENEX is a dietary supplement of insoluble polysaccharides, of Lactobacillus Casei (specific type) and of Bifidobacterium Lactis (specific type). These subspecies of probiotics bacteria have been ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- stage IIIa-IIIc (AJCC/TNM)
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01477866
Last Update
December 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Palermo
Palermo, PA, Italy, 90129